Skip to Content

Diasorin SpA DSRLF

Morningstar Rating
$88.45 −3.77 (4.09%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DSRLF is trading at a 1% discount.
Price
$88.01
Fair Value
$75.98
Uncertainty
High
1-Star Price
$257.86
5-Star Price
$89.99
Economic Moat
Bfxwxw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DSRLF is a good fit for your portfolio.

Trading Information

Previous Close Price
$92.22
Day Range
$88.4588.45
52-Week Range
$86.00120.00
Bid/Ask
$92.84 / $100.78
Market Cap
$4.71 Bil
Volume/Avg
4 / 85

Key Statistics

Price/Earnings (Normalized)
16.09
Price/Sales
3.97
Dividend Yield (Trailing)
1.34%
Dividend Yield (Forward)
1.41%
Total Yield
1.73%

Company Profile

Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
3,233

Comparables

Valuation

Metric
DSRLF
CIR
ISP
Price/Earnings (Normalized)
16.0942.267.92
Price/Book Value
2.830.811.09
Price/Sales
3.970.262.37
Price/Cash Flow
14.562.455.73
Price/Earnings
DSRLF
CIR
ISP

Financial Strength

Metric
DSRLF
CIR
ISP
Quick Ratio
1.611.05
Current Ratio
2.761.32
Interest Coverage
7.331.78
Quick Ratio
DSRLF
CIR
ISP

Profitability

Metric
DSRLF
CIR
ISP
Return on Assets (Normalized)
7.57%1.22%0.82%
Return on Equity (Normalized)
14.94%5.52%14.26%
Return on Invested Capital (Normalized)
11.85%2.72%
Return on Assets
DSRLF
CIR
ISP
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncHxrxjxvvxNssj$206.7 Bil
DHR
Danaher CorpRvzmdgbkcdCxzvb$175.0 Bil
IQV
IQVIA Holdings IncSjkmhvmytDnjgrr$41.3 Bil
IDXX
IDEXX Laboratories IncQdyvdzfmcSjkdd$39.7 Bil
A
Agilent Technologies IncFqnvnctmbmMgjy$38.8 Bil
MTD
Mettler-Toledo International IncPnzrjvctzbXxgdfd$25.5 Bil
ICLR
Icon PLCKjvgmjxSlmwv$24.1 Bil
ILMN
Illumina IncHcrrvnrmXvyrsrm$18.6 Bil
WAT
Waters CorpKphlrvjttNdyt$18.0 Bil
LH
Laboratory Corp of America HoldingsCdgyzhlrzSvngnc$16.8 Bil

Sponsor Center